Published on in Vol 25 (2023)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/46891, first published
.
Journals
- Chen C, Zhang W, Yan G, Tang C. Identifying metabolic dysfunction-associated steatotic liver disease in patients with hypertension and pre-hypertension: An interpretable machine learning approach. DIGITAL HEALTH 2024;10 View
- Lv J, Zhang Y, Li X, Guo H, Yang C. The burden of non-alcoholic fatty liver disease among working-age people in the Western Pacific Region, 1990–2019: an age–period–cohort analysis of the Global Burden of Disease study. BMC Public Health 2024;24(1) View
- Yang B, Lu H, Ran Y. Advancing non-alcoholic fatty liver disease prediction: a comprehensive machine learning approach integrating SHAP interpretability and multi-cohort validation. Frontiers in Endocrinology 2024;15 View
- Liu L, Liang L, Luo Y, Han J, Lu D, Cai R, Sethi G, Mai S. Unveiling the Power of Gut Microbiome in Predicting Neoadjuvant Immunochemotherapy Responses in Esophageal Squamous Cell Carcinoma. Research 2024;7 View